Skip to content
Review Open access

Intramyocellular lipid droplet–mitochondria uncoupling drives muscle atrophy via metabolite-directed epigenetic reprogramming: a review

Oct 2026 · Frontiers in Endocrinology · Vol 17 · 0 citations · 168 references
Medicine

TL;DR

This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming that drives chronic intramyocellular lipid accumulation and lock the tissue in a catabolic transcriptional state.

Abstract

Type 2 diabetes mellitus (T2DM)-associated sarcopenia is driven by protein degradation and impaired myogenic regeneration. While classical models emphasize cytosolic kinase pathways, the subcellular mechanisms mediating lipotoxicity-induced chronic catabolism remain incompletely understood. This review elucidates a tripartite pathological cascade comprising organelle structural uncoupling, metabolic intermediate overflow, and epigenetic reprogramming. Chronic intramyocellular lipid accumulation disrupts lipid droplet–mitochondria contact (LDMC) sites, largely via Mfn2 modification. This spatial dissociation impairs mitochondrial oxidation, driving the nucleocytoplasmic accumulation of polar metabolites, specifically Acetyl-CoA, succinate, and lactate. Acting as covalent substrates or competitive inhibitors, these metabolites modulate histone-modifying enzymes such as p300/CBP and JmjC-domain demethylases. Consequently, this substrate-driven epigenetic remodeling increases chromatin accessibility at E3 ubiquitin ligase promoters (Atrogin-1, MuRF1) and concurrently represses myogenic loci (MyoD, MyoG), locking the tissue in a catabolic transcriptional state. Effective interventions must target this organelle-metabolite-epigenetic axis. Beyond systemic agents like SGLT2 inhibitors and GLP-1 receptor agonists, precision strategies—including repairing LDMC topology, bypassing enzymatic bottlenecks via CPT1 or LDHA, and restoring epigenetic homeostasis—are necessary to preserve lean mass and maintain skeletal muscle under metabolic stress.

Read PDF

Similar papers

Open access Sep 2026

Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ

Aging paradoxically leads to both a decline in skeletal muscle mitochondrial function and a shift in muscle composition that favors fibers rich in mitochondria. Yet the biological rationale and mechanism underlying this phenomenon remain largely unknown. Here we show that synthesis of the mitochondrial membrane lipid,...

Fabian Finger, Mikkel Frost, Shinya Watanabe et al. · 2 citations
#gene editing Review Open access Oct 2026

Mechanisms of Lipid Droplet-Mitochondria Interactions and Their Roles in Diseases.

In the future, integration of protein regulation, gene editing technologies, and precision therapeutic approaches may enable specific targeting of LD-mitochondria communication, thereby offering new avenues for the treatment of relevant diseases.

Yang Ding, X. Xie, Yang-Kun Li et al. · 0 citations
Review Open access Oct 2026

Lipid droplet–mitochondria crosstalk in osteoarthritis: linking lipid routing to metabolic mismatch

Osteoarthritis (OA) is a whole-joint disease characterized by metabolic reprogramming beyond structural degeneration. Increasing evidence indicates that lipid droplets (LDs) regulate lipid storage, mobilization and intracellular lipid routing, while alterations in mitochondrial metabolism determine the capacity of chon...

Gang Meng, Rui-Jie Hou, Ping Dong et al. · 0 citations
Open access Sep 2026

Metabolic-Epigenetic Coupling in Cellular Senescence: In Silico Cristae Remodeling Depletes Alpha-Ketoglutarate to Drive KDM4/6 Inhibition and SASP Amplification

Cellular senescence is defined by stable cell-cycle withdrawal coupled with a hyper-secretory pro-inflammatory phenotype termed the senescence-associated secretory phenotype (SASP). While canonical paradigms emphasize persistent nuclear DNA damage response (DDR) signaling as the primary driver of the SASP, increasing e...

Mathieu Maclos, J. Dyer · 0 citations
Review Open access Sep 2026

Mitochondria-associated programmed cell death in colorectal cancer: molecular mechanisms, metabolic plasticity, and therapeutic opportunities.

Mitochondria integrate bioenergetics, redox homeostasis, calcium signaling, metabolite synthesis, organelle quality control, innate immune sensing, and regulated cell death. In colorectal cancer (CRC), mitochondrial function is not simply suppressed by aerobic glycolysis; rather, tumor cells dynamically redistribute fl...

Shao-Jie Liu, Jia-Qi Zhang, Zi-Han Zhang et al. · 0 citations
Open access Oct 2026

Carnitine acetyltransferase (CrAT)-Solute Carrier Family 25 Member 20 (SLC25A20) mediated acetylcarnitine shuttle links lipid oxidation to epigenetic control of cardiac metabolic maturation

During postnatal development, cardiomyocytes experience marked upregulation of lipid metabolism genes, which drives the transition from glycolysis to fatty acid β-oxidation (FAO). Fatty acids (FA) insufficiency hinders the maturation of induced pluripotent stem cell-derived cardiomyocytes, yet the underlying mech...

D. Guo, L. Hu, Y. Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.